<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals Ltd has informed BSE that it does not qualify as a 'Large Corporate' under the SEBI circular dated November 26, 2018, which deals with fund raising through debt securities by large entities. Because the company falls outside the prescribed large corporate criteria, it is exempt from submitting the Initial Disclosure in the Annexure-A format required by that circular. The filing, dated April 22, 2025, is a routine compliance declaration sent to the BSE listing department. The company's scrip code is 524632 and it is registered in Ahmedabad, Gujarat.
This is a routine regulatory clarification with no material effect on the business, financials, or shareholders. It simply confirms the company is too small to fall under SEBI's large corporate debt disclosure rules and therefore has no extra compliance burden.